Skip to main content
. 2020 Dec 22;14(2):100987. doi: 10.1016/j.tranon.2020.100987

Fig. 5.

Fig. 5

β-catenin knockdown increases sensitivity to a PARPi or cisplatin in ovarian cancer cells.

HeyA8 and SKOV3 cells were transfected with either β-catenin inhibitor FH535 or ctrl. Cell viability was assayed by CCK8 assay (A–D) and clonogenic cell-survival assay (E,F).